Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Catalyst Pharmaceutical Partners Provides Update on Research and Development Pipeline
Feb. 12, 2013
Catalyst Pharmaceutical, a specialty pharmaceutical company focused on the development and commercialization of novel prescription drugs targeting rare (orphan) neurological diseases and disorders, today provided an update on its research and development pipeline.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing